Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2025-12-25 @ 10:57 PM
NCT ID: NCT01993667
Description: None
Frequency Threshold: 0
Time Frame: 12 days
Study: NCT01993667
Study Brief: Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Acetazolamide Normal Dose Experimental : Acetazolamide 125 mg twice daily Acetazolamide: Administration of low dose acetazolamide 0 None 0 43 0 43 View
Acetazolamide Low Dose Experimental: Acetazolamide 62.5 mg twice daily Acetazolamide: Administration of low dose acetazolamide 0 None 0 47 0 47 View
Serious Events(If Any):
Other Events(If Any):